Aclarion Inc (ACON) Stock Price, Quote & News

Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs whi...

Industry: Health Information Services

Sector: Healthcare

Phone: 833 275 2266

Website: www.aclarion.com

Address:

8181 Arista Place, Suite 100, Broomfield, United States

Schizoo Oct. 24 at 6:40 PM

$IXHL $ONCO $ACON have a great weekend all.. see ya next week.. BALLS N PATIENCE... RisK rEtarD 😘🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

0 · Reply

Putnik Oct. 24 at 4:41 PM

$ACON ready for next bigger rip. Added a few more!

0 · Reply

Schizoo Oct. 24 at 3:28 PM

$ACON 😘

0 · Reply

Schizoo Oct. 24 at 1:57 PM

$ACON

0 · Reply

TurskaInTar Oct. 22 at 11:47 AM

$ACON A buy order filled yesterday before closing at 7.83...seems to have good support there (and a volume spike on a low volume day), hope it holds.

1 · Reply

MrWhiskIt Oct. 22 at 7:46 AM

$ACON Hello? 👀 $YYAI

0 · Reply

Putnik Oct. 21 at 2:50 AM

$ACON I don’t care about $SUGP. Now let’s get this back to 18 to 20

1 · Reply

SpartanVI Oct. 18 at 7:16 PM

$SUGP $STFS $ACON $COOT $LNKS https://youtu.be/VWImYEi5EOc?si=cfM-hj1SvdynjLH2 🔥👀

0 · Reply

MRWILL_ Oct. 18 at 4:15 PM

$SUGP $STFS $ACON $COOT $LNKS

0 · Reply

Paraboljoker Oct. 18 at 3:46 PM

$SUGP $STFS $ACON $COOT $LNKS

0 · Reply

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

Oct 9, 2025, 6:00 AM EDT - 16 days ago

Aclarion to Present at the LD Micro Main Event XIX

Jun 24, 2025, 7:00 AM EDT - 4 months ago

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

May 20, 2025, 6:00 AM EDT - 5 months ago

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

May 12, 2025, 7:34 AM EDT - 5 months ago

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Apr 29, 2025, 6:00 AM EDT - 6 months ago

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Apr 23, 2025, 6:00 AM EDT - 6 months ago

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Apr 21, 2025, 6:00 AM EDT - 6 months ago

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 9, 2025, 7:00 AM EDT - 7 months ago

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 2, 2025, 6:00 AM EDT - 7 months ago

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Mar 31, 2025, 7:00 AM EDT - 7 months ago

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 13, 2025, 9:25 AM EDT - 8 months ago

Aclarion Provides Shareholder Update

Mar 6, 2025, 9:35 AM EST - 8 months ago

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Mar 3, 2025, 6:00 AM EST - 8 months ago

Aclarion Announces First Commercial Agreement with Scripps Health

Feb 20, 2025, 6:00 AM EST - 8 months ago

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Feb 11, 2025, 7:58 AM EST - 9 months ago

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Feb 6, 2025, 7:23 AM EST - 9 months ago

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Feb 4, 2025, 7:23 AM EST - 9 months ago

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Nov 21, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Nov 14, 2024, 5:00 PM EST - 1 year ago

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 27, 2024, 6:57 AM EDT - 1 year ago

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Sep 13, 2024, 8:30 AM EDT - 1 year ago

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 12, 2024, 6:57 AM EDT - 1 year ago

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Sep 10, 2024, 6:57 AM EDT - 1 year ago

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Sep 5, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Aug 29, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aug 21, 2024, 7:57 AM EDT - 1 year ago

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aug 15, 2024, 9:48 AM EDT - 1 year ago

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aug 14, 2024, 8:08 AM EDT - 1 year ago

Aclarion Announces First Commercial Agreement in Michigan

Aug 13, 2024, 9:07 AM EDT - 1 year ago

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Jun 25, 2024, 8:30 AM EDT - 1 year ago

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Apr 25, 2024, 9:14 AM EDT - 1 year ago

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Feb 27, 2024, 3:22 PM EST - 1 year ago

Aclarion Announces Closing of $3.0 Million Public Offering

Feb 26, 2024, 9:15 AM EST - 1 year ago

Aclarion Announces Pricing of $3.0 Million Public Offering

Feb 5, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Jan 22, 2024, 8:00 AM EST - 1 year ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Nov 27, 2023, 8:00 AM EST - 2 years ago

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Nov 6, 2023, 8:00 AM EST - 2 years ago

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Oct 24, 2023, 8:45 AM EDT - 2 years ago

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Oct 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Aug 25, 2023, 4:10 PM EDT - 2 years ago

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Jun 14, 2023, 11:27 AM EDT - 2 years ago

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Jun 8, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

May 30, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

May 23, 2023, 7:30 AM EDT - 2 years ago

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

May 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion, Inc. Announces Delayed 10-Q Filing

Schizoo Oct. 24 at 6:40 PM

$IXHL $ONCO $ACON have a great weekend all.. see ya next week.. BALLS N PATIENCE... RisK rEtarD 😘🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

0 · Reply

Putnik Oct. 24 at 4:41 PM

$ACON ready for next bigger rip. Added a few more!

0 · Reply

Schizoo Oct. 24 at 3:28 PM

$ACON 😘

0 · Reply

Schizoo Oct. 24 at 1:57 PM

$ACON

0 · Reply

TurskaInTar Oct. 22 at 11:47 AM

$ACON A buy order filled yesterday before closing at 7.83...seems to have good support there (and a volume spike on a low volume day), hope it holds.

1 · Reply

MrWhiskIt Oct. 22 at 7:46 AM

$ACON Hello? 👀 $YYAI

0 · Reply

Putnik Oct. 21 at 2:50 AM

$ACON I don’t care about $SUGP. Now let’s get this back to 18 to 20

1 · Reply

SpartanVI Oct. 18 at 7:16 PM

$SUGP $STFS $ACON $COOT $LNKS https://youtu.be/VWImYEi5EOc?si=cfM-hj1SvdynjLH2 🔥👀

0 · Reply

MRWILL_ Oct. 18 at 4:15 PM

$SUGP $STFS $ACON $COOT $LNKS

0 · Reply

Paraboljoker Oct. 18 at 3:46 PM

$SUGP $STFS $ACON $COOT $LNKS

0 · Reply

SpartanVI Oct. 18 at 3:22 PM

$SUGP Wont need much to get above 20$+ just saying Crazy small float 70%+ insider held 400k float 🌋👇 $STFS $ACON $COOT $LNKS

1 · Reply

Daily1515 Oct. 17 at 9:58 PM

$RANI $ACON up next

0 · Reply

Putnik Oct. 17 at 9:08 PM

$ACON

0 · Reply

ZoneWhisper Oct. 17 at 6:21 PM

$ACON Tight floats plus catalysts equal potential squeezes. Add one high profile partnership and volumes can jump five or ten times day over day. With thin supply, price discovery can overshoot intrinsic value on both directions which favors prepared holders

0 · Reply

Fadda Oct. 17 at 1:32 AM

$ACHV $ACON $ARTV $FEMY $KMRK

1 · Reply

dbr_island Oct. 17 at 1:32 AM

🔥 LETS END THE WEEK STRONG BULLS 🔥 If you’re reading this just know that there are opportunities to make LIFE CHANGING gains EVERY DAY Bull market, Bear market… it doesn’t matter This market lately is designed to have 100% runners almost consistently You just need to know how to play the game and be in the know BEFORE the crowd Been doing this for over 23 years so I understand market behavior You have seen the results I have changed my life Now my focus is YOU 🫵 I want to CHANGE lives I have changed many lives There is no feeling like it And I’m here to do it again I wish each one of you reading this a successful day, week, year, and beyond ❤️ $ARTV $ACON $KMRK $ACHV $FEMY see you all tomorrow!

0 · Reply

ROCKET_MAGIC Oct. 16 at 2:43 PM

$ACON ☠️☠️☠️☠️☠️ TOXIC 3 Reverse Splits decimating shareholders. $150M Shelf Filed. WHEN is the 4th Reverse? ⬇️ In my opinion.

1 · Reply

TurskaInTar Oct. 16 at 5:45 AM

$ACON Déjà-vu? 😂

0 · Reply

TurskaInTar Oct. 16 at 5:38 AM

$ACON Strong close yesterday 😎 Chart looks nice, also strong technicals (daily). Lets get that $22 😁😁

0 · Reply

NewbieMoveOver Oct. 16 at 1:15 AM

$ACON they just keep on adding to their network ❤️

0 · Reply

Putnik Oct. 15 at 8:29 PM

$ACON send it for real this time!

0 · Reply

Putnik Oct. 15 at 4:24 PM

$ACON I know you gonna run soon for us again!

0 · Reply

Market Cap	4.44M
Revenue (ttm)	50,000.00
Net Income (ttm)	-6.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-13,980.00%
Debt to Equity Ratio	0.00

Volume	42,000
Avg Vol	170,626
Day's Range	N/A - N/A
Shares Out	582,000.00
Stochastic %K	18%
Beta	1.40
Analysts	Sell
Price Target	$22.00